The review discusses fifty eight peptides in numerous clinical phases, indicating a robust pipeline of peptide therapies targeting PPIs. Clinical trials and preclinical studies are highlighted, showing the efficacy of peptide vaccines in inducing an immune response, with the opportunity to further improve survival prices for HCC people. Systematic Evaluation https://billj864qwx4.wikirecognition.com/user